Analyze Diet
Stem cell research & therapy2020; 11(1); 184; doi: 10.1186/s13287-020-01692-w

Genome-wide transcriptome analysis reveals equine embryonic stem cell-derived tenocytes resemble fetal, not adult tenocytes.

Abstract: Tendon injuries occur frequently in human and equine athletes. Treatment options are limited, and the prognosis is often poor with functionally deficient scar tissue resulting. Fetal tendon injuries in contrast are capable of healing without forming scar tissue. Embryonic stem cells (ESCs) may provide a potential cellular therapeutic to improve adult tendon regeneration; however, whether they can mimic the properties of fetal tenocytes is unknown. To this end, understanding the unique expression profile of normal adult and fetal tenocytes is crucial to allow validation of ESC-derived tenocytes as a cellular therapeutic. Equine adult, fetal and ESC-derived tenocytes were cultured in a three-dimensional environment, with histological, morphological and transcriptomic differences compared. Additionally, the effects on gene expression of culturing adult and fetal tenocytes in either conventional two-dimensional monolayer culture or three-dimensional culture were compared using RNA sequencing. No qualitative differences in three-dimensional tendon constructs generated from adult, fetal and ESCs were found using histological and morphological analysis. However, genome-wide transcriptomic analysis using RNA sequencing revealed that ESC-derived tenocytes' transcriptomic profile more closely resembled fetal tenocytes as opposed to adult tenocytes. Furthermore, this study adds to the growing evidence that monolayer cultured cells' gene expression profiles converge, with adult and fetal tenocytes having only 10 significantly different genes when cultured in this manner. In contrast, when adult and fetal tenocytes were cultured in 3D, large distinctions in gene expression between these two developmental stages were found, with 542 genes being differentially expressed. The information provided in this study makes a significant contribution to the investigation into the differences between adult reparative and fetal regenerative cells and supports the concept of using ESC-derived tenocytes as a cellular therapy. Comparing two- and three-dimensional culture also indicates three-dimensional culture as being a more physiologically relevant culture system for determining transcriptomic difference between the same cell types from different developmental stages.
Publication Date: 2020-05-19 PubMed ID: 32430075PubMed Central: PMC7238619DOI: 10.1186/s13287-020-01692-wGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study demonstrates that embryonic stem cells (ESCs) can mimic the properties of fetal tendon cells (tenocytes) rather than adult tenocytes — an insight that may inform future strategies for improving tendon repair in adult humans and horses.

Understanding the Study

The study centers on two key problems encountered in the treatment of tendon injuries:

  • Despite current treatments, such injuries usually heal poorly, often resulting in the formation of deficient scar tissue that affects functionality.
  • In stark contrast, fetal tendon injuries can heal without scar tissue formation, suggesting a potential role for ESCs in improving adult tendon regeneration.

Methodology

The research was focused on examining the similarities and differences between normal adult, fetal, and ESC-derived tenocytes:

  • These three variants of tenocytes were cultured in a three-dimensional environment.
  • Different aspects such as histological, morphological, and transcriptomic were compared among the tenocytes.
  • Study also included comparison of gene expression effects in adult and fetal tenocytes cultured in two different ways: traditional two-dimensional monolayer culture and three-dimensional culture.

Findings

Key findings of this research centered around the properties of ESC-derived tenocytes and the differences in gene expression profiles of adult versus fetal tenocytes in different culture environments:

  • A significant discovery here is that ESC-derived tenocytes’ transcriptomic profile resembled more with fetal tenocytes than adult tenocytes.
  • No noteworthy differences were found in the tendon constructs created using adult, fetal and ESCs in terms of histological and morphological analysis.
  • In two-dimensional cell culture, both adult and fetal tenocytes had similar gene expression profiles, differing only in 10 genes.
  • However, in three-dimensional culture, there were significant gene expression differences between adult and fetal tenocytes, with 542 genes being differentially expressed.

Significance of the Study

This research contributes to the broader understanding of cellular differences between adult and fetal tendon cells and supports the idea of using ESC-derived tenocytes as a potential cellular therapy for tendon injuries. The comparison between two- and three-dimensional culture methods also suggests that three-dimensional culture is more physiologically relevant for detecting transcriptomic differences between the same cell types from different stages of development.

Cite This Article

APA
Paterson YZ, Cribbs A, Espenel M, Smith EJ, Henson FMD, Guest DJ. (2020). Genome-wide transcriptome analysis reveals equine embryonic stem cell-derived tenocytes resemble fetal, not adult tenocytes. Stem Cell Res Ther, 11(1), 184. https://doi.org/10.1186/s13287-020-01692-w

Publication

ISSN: 1757-6512
NlmUniqueID: 101527581
Country: England
Language: English
Volume: 11
Issue: 1
Pages: 184
PII: 184

Researcher Affiliations

Paterson, Y Z
  • Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK. yzp20@cam.ac.uk.
  • Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, UK. yzp20@cam.ac.uk.
Cribbs, A
  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Espenel, M
  • Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, UK.
Smith, E J
  • Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, UK.
Henson, F M D
  • Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK.
  • Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, UK.
Guest, D J
  • Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, UK.

MeSH Terms

  • Animals
  • Cell Differentiation
  • Cells, Cultured
  • Embryonic Stem Cells
  • Gene Expression Profiling
  • Horses
  • Humans
  • Tendons
  • Tenocytes

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 99 references
  1. Kannus P. Tendons--a source of major concern in competitive and recreational athletes.. Scand J Med Sci Sports 1997 Apr;7(2):53-4.
    pubmed: 9211603
  2. Lesic A, Bumbasirevic M. Disorders of the Achilles tendon. Curr Orthop 2004;18:63–75.
  3. Patterson-Kane JC, Rich T. Achilles tendon injuries in elite athletes: lessons in pathophysiology from their equine counterparts.. ILAR J 2014;55(1):86-99.
    pubmed: 24936032doi: 10.1093/ilar/ilu004google scholar: lookup
  4. Molloy A, Wood EV. Complications of the treatment of Achilles tendon ruptures.. Foot Ankle Clin 2009 Dec;14(4):745-59.
    pubmed: 19857846doi: 10.1016/j.fcl.2009.07.004google scholar: lookup
  5. Beredjiklian PK, Favata M, Cartmell JS, Flanagan CL, Crombleholme TM, Soslowsky LJ. Regenerative versus reparative healing in tendon: a study of biomechanical and histological properties in fetal sheep.. Ann Biomed Eng 2003 Nov;31(10):1143-52.
    pubmed: 14649488doi: 10.1114/1.1616931google scholar: lookup
  6. Favata M, Beredjiklian PK, Zgonis MH, Beason DP, Crombleholme TM, Jawad AF, Soslowsky LJ. Regenerative properties of fetal sheep tendon are not adversely affected by transplantation into an adult environment.. J Orthop Res 2006 Nov;24(11):2124-32.
    pubmed: 16944473doi: 10.1002/jor.20271google scholar: lookup
  7. Rowlatt U. Intrauterine wound healing in a 20 week human fetus.. Virchows Arch A Pathol Anat Histol 1979 Mar 23;381(3):353-61.
    pubmed: 155931doi: 10.1007/bf00432477google scholar: lookup
  8. Slate RK, Posnick JC, Wells MD, Goldstein JA, Keeley FW, Thorner PS. Fetal tibial bone healing in utero: the effects of miniplate fixation.. Plast Reconstr Surg 1993 Oct;92(5):874-83.
    pubmed: 8415969
  9. Lin KY, Posnick JC, al-Qattan MM, Vajsar J, Becker LE. Fetal nerve healing: an experimental study.. Plast Reconstr Surg 1994 Jun;93(7):1323-33.
    pubmed: 8208799
  10. Coolen NA, Schouten KC, Middelkoop E, Ulrich MM. Comparison between human fetal and adult skin.. Arch Dermatol Res 2010 Jan;302(1):47-55.
    pmc: PMC2799629pubmed: 19701759doi: 10.1007/s00403-009-0989-8google scholar: lookup
  11. Longaker MT, Whitby DJ, Ferguson MW, Lorenz HP, Harrison MR, Adzick NS. Adult skin wounds in the fetal environment heal with scar formation.. Ann Surg 1994 Jan;219(1):65-72.
  12. Stalling SS, Nicoll SB. Fetal ACL fibroblasts exhibit enhanced cellular properties compared with adults.. Clin Orthop Relat Res 2008 Dec;466(12):3130-7.
    pmc: PMC2628219pubmed: 18648900doi: 10.1007/s11999-008-0391-4google scholar: lookup
  13. Tang QM, Chen JL, Shen WL, Yin Z, Liu HH, Fang Z, Heng BC, Ouyang HW, Chen X. Fetal and adult fibroblasts display intrinsic differences in tendon tissue engineering and regeneration.. Sci Rep 2014 Jul 3;4:5515.
    pmc: PMC4080701pubmed: 24992450doi: 10.1038/srep05515google scholar: lookup
  14. De Buys Roessingh AS, Hohlfeld J, Scaletta C, Hirt-Burri N, Gerber S, Hohlfeld P, Gebbers JO, Applegate LA. Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing.. Cell Transplant 2006;15(8-9):823-34.
    pubmed: 17269452doi: 10.3727/000000006783981459google scholar: lookup
  15. Norbury WB, Jeschke MG, Herndon DN. Tissue engineered fetal skin constructs for pediatric burns.. Crit Care 2005;9(6):533-4.
    pmc: PMC1414054pubmed: 16356232doi: 10.1186/cc3881google scholar: lookup
  16. Grognuz A, Scaletta C, Farron A, Raffoul W, Applegate LA. Human Fetal Progenitor Tenocytes for Regenerative Medicine.. Cell Transplant 2016;25(3):463-79.
    pubmed: 26110286doi: 10.3727/096368915x688515google scholar: lookup
  17. Watts AE, Yeager AE, Kopyov OV, Nixon AJ. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.. Stem Cell Res Ther 2011 Jan 27;2(1):4.
    pmc: PMC3092144pubmed: 21272343doi: 10.1186/scrt45google scholar: lookup
  18. (HHS) D of H and HS. Statement from the Department of Health and Human Services. 2019.
  19. von der Mark K, Gauss V, von der Mark H, Müller P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture.. Nature 1977 Jun 9;267(5611):531-2.
    pubmed: 559947doi: 10.1038/267531a0google scholar: lookup
  20. Lee KS, Cha SH, Kang HW, Song JY, Lee KW, Ko KB, Lee HT. Effects of serial passage on the characteristics and chondrogenic differentiation of canine umbilical cord matrix derived mesenchymal stem cells.. Asian-Australas J Anim Sci 2013 Apr;26(4):588-95.
    pmc: PMC4093376pubmed: 25049827doi: 10.5713/ajas.2012.12488google scholar: lookup
  21. Wall ME, Bernacki SH, Loboa EG. Effects of serial passaging on the adipogenic and osteogenic differentiation potential of adipose-derived human mesenchymal stem cells.. Tissue Eng 2007 Jun;13(6):1291-8.
    pubmed: 17518709doi: 10.1089/ten.2006.0275google scholar: lookup
  22. Mouriaux F, Zaniolo K, Bergeron MA, Weidmann C, De La Fouchardière A, Fournier F, Droit A, Morcos MW, Landreville S, Guérin SL. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors.. Invest Ophthalmol Vis Sci 2016 Oct 1;57(13):5288-5301.
    pubmed: 27723895doi: 10.1167/iovs.16-19317google scholar: lookup
  23. Mueller AJ, Tew SR, Vasieva O, Clegg PD, Canty-Laird EG. A systems biology approach to defining regulatory mechanisms for cartilage and tendon cell phenotypes.. Sci Rep 2016 Sep 27;6:33956.
    pmc: PMC5037390pubmed: 27670352doi: 10.1038/srep33956google scholar: lookup
  24. Fortier LA, Travis AJ. Stem cells in veterinary medicine.. Stem Cell Res Ther 2011 Feb 23;2(1):9.
    pmc: PMC3092149pubmed: 21371354doi: 10.1186/scrt50google scholar: lookup
  25. Broeckx SY, Martens AM, Bertone AL, Van Brantegem L, Duchateau L, Van Hecke L, Dumoulin M, Oosterlinck M, Chiers K, Hussein H, Pille F, Spaas JH. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.. Equine Vet J 2019 Nov;51(6):787-794.
    pmc: PMC6850029pubmed: 30815897doi: 10.1111/evj.13089google scholar: lookup
  26. Saville V. Status of equine stem cell-based veterinary medicine in the UK.. Vet Rec 2019 Nov 9;185(18):575.
    pubmed: 31699867doi: 10.1136/vr.l6272google scholar: lookup
  27. Jo CH, Chai JW, Jeong EC, Oh S, Kim PS, Yoon JY, Yoon KS. Intratendinous Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Rotator Cuff Disease: A First-In-Human Trial.. Stem Cells 2018 Sep;36(9):1441-1450.
    pubmed: 29790618doi: 10.1002/stem.2855google scholar: lookup
  28. Hoogduijn MJ, Lombardo E. Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review.. Stem Cells Transl Med 2019 Nov;8(11):1126-1134.
    pmc: PMC6811696pubmed: 31282113doi: 10.1002/sctm.19-0073google scholar: lookup
  29. Guest DJ, Smith MR, Allen WR. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.. Equine Vet J 2010 Oct;42(7):636-42.
  30. Moya A, Paquet J, Deschepper M, Larochette N, Oudina K, Denoeud C, Bensidhoum M, Logeart-Avramoglou D, Petite H. Human Mesenchymal Stem Cell Failure to Adapt to Glucose Shortage and Rapidly Use Intracellular Energy Reserves Through Glycolysis Explains Poor Cell Survival After Implantation.. Stem Cells 2018 Mar;36(3):363-376.
    pubmed: 29266629doi: 10.1002/stem.2763google scholar: lookup
  31. Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, Baan CC, Dahlke MH, Hoogduijn MJ. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion.. Front Immunol 2012;3:297.
    pmc: PMC3458305pubmed: 23056000doi: 10.3389/fimmu.2012.00297google scholar: lookup
  32. Paterson YZ, Rash N, Garvican ER, Paillot R, Guest DJ. Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.. Stem Cell Res Ther 2014 Jul 30;5(4):90.
    pmc: PMC4247727pubmed: 25080326doi: 10.1186/scrt479google scholar: lookup
  33. Weiss ARR, Dahlke MH. Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs.. Front Immunol 2019;10:1191.
    pmc: PMC6557979pubmed: 31214172doi: 10.3389/fimmu.2019.01191google scholar: lookup
  34. Romito A, Cobellis G. Pluripotent Stem Cells: Current Understanding and Future Directions.. Stem Cells Int 2016;2016:9451492.
    pmc: PMC4699068pubmed: 26798367doi: 10.1155/2016/9451492google scholar: lookup
  35. Buzzard JJ, Gough NM, Crook JM, Colman A. Karyotype of human ES cells during extended culture.. Nat Biotechnol 2004 Apr;22(4):381-2; author reply 382.
    pubmed: 15060545doi: 10.1038/nbt0404-381google scholar: lookup
  36. Mitalipova MM, Rao RR, Hoyer DM, Johnson JA, Meisner LF, Jones KL, Dalton S, Stice SL. Preserving the genetic integrity of human embryonic stem cells.. Nat Biotechnol 2005 Jan;23(1):19-20.
    pubmed: 15637610doi: 10.1038/nbt0105-19google scholar: lookup
  37. Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, Fairchild PJ. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance.. Proc Natl Acad Sci U S A 2007 Dec 26;104(52):20920-5.
    pmc: PMC2409242pubmed: 18093946doi: 10.1073/pnas.0710265105google scholar: lookup
  38. Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, Ferber I, Lebkowski J, Martin T, Madrenas J, Bhatia M. Human embryonic stem cells possess immune-privileged properties.. Stem Cells 2004;22(4):448-56.
    pubmed: 15277692doi: 10.1634/stemcells.22-4-448google scholar: lookup
  39. McClellan A, Paterson YZ, Paillot R, Guest DJ. Equine Fetal, Adult, and Embryonic Stem Cell-Derived Tenocytes Are All Immune Privileged but Exhibit Different Immune Suppressive Properties In Vitro.. Stem Cells Dev 2019 Nov 1;28(21):1413-1423.
    pubmed: 31507234doi: 10.1089/scd.2019.0120google scholar: lookup
  40. Li X, Zhou SG, Imreh MP, Ahrlund-Richter L, Allen WR. Horse embryonic stem cell lines from the proliferation of inner cell mass cells.. Stem Cells Dev 2006 Aug;15(4):523-31.
    pubmed: 16978056doi: 10.1089/scd.2006.15.523google scholar: lookup
  41. Guest DJ, Allen WR. Expression of cell-surface antigens and embryonic stem cell pluripotency genes in equine blastocysts.. Stem Cells Dev 2007 Oct;16(5):789-96.
    pubmed: 17999600doi: 10.1089/scd.2007.0032google scholar: lookup
  42. Barsby T, Guest D. Transforming growth factor beta3 promotes tendon differentiation of equine embryo-derived stem cells.. Tissue Eng Part A 2013 Oct;19(19-20):2156-65.
    pubmed: 23611525doi: 10.1089/ten.tea.2012.0372google scholar: lookup
  43. Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, Dunn NR. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies.. Stem Cell Res 2009 May;2(3):198-210.
    pubmed: 19393593doi: 10.1016/j.scr.2009.02.002google scholar: lookup
  44. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD, D'Amour KA, Carpenter MK, Baetge EE. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.. Nat Biotechnol 2008 Apr;26(4):443-52.
    pubmed: 18288110doi: 10.1038/nbt1393google scholar: lookup
  45. Laflamme MA, Gold J, Xu C, Hassanipour M, Rosler E, Police S, Muskheli V, Murry CE. Formation of human myocardium in the rat heart from human embryonic stem cells.. Am J Pathol 2005 Sep;167(3):663-71.
  46. Reubinoff BE, Itsykson P, Turetsky T, Pera MF, Reinhartz E, Itzik A, Ben-Hur T. Neural progenitors from human embryonic stem cells.. Nat Biotechnol 2001 Dec;19(12):1134-40.
    pubmed: 11731782doi: 10.1038/nbt1201-1134google scholar: lookup
  47. Tomescot A, Leschik J, Bellamy V, Dubois G, Messas E, Bruneval P, Desnos M, Hagège AA, Amit M, Itskovitz J, Menasché P, Pucéat M. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.. Stem Cells 2007 Sep;25(9):2200-5.
    pubmed: 17540853doi: 10.1634/stemcells.2007-0133google scholar: lookup
  48. Guo XM, Zhao YS, Chang HX, Wang CY, E LL, Zhang XA, Duan CM, Dong LZ, Jiang H, Li J, Song Y, Yang XJ. Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells.. Circulation 2006 May 9;113(18):2229-37.
  49. Kumashiro Y, Asahina K, Ozeki R, Shimizu-Saito K, Tanaka Y, Kida Y, Inoue K, Kaneko M, Sato T, Teramoto K, Arii S, Teraoka H. Enrichment of hepatocytes differentiated from mouse embryonic stem cells as a transplantable source.. Transplantation 2005 Mar 15;79(5):550-7.
  50. Barsby T, Bavin EP, Guest DJ. Three-dimensional culture and transforming growth factor beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cells.. Tissue Eng Part A 2014 Oct;20(19-20):2604-13.
    pmc: PMC4195467pubmed: 24628376doi: 10.1089/ten.tea.2013.0457google scholar: lookup
  51. Shojaee A, Parham A. Strategies of tenogenic differentiation of equine stem cells for tendon repair: current status and challenges.. Stem Cell Res Ther 2019 Jun 18;10(1):181.
    pmc: PMC6582602pubmed: 31215490doi: 10.1186/s13287-019-1291-0google scholar: lookup
  52. Chen X, Song XH, Yin Z, Zou XH, Wang LL, Hu H, Cao T, Zheng M, Ouyang HW. Stepwise differentiation of human embryonic stem cells promotes tendon regeneration by secreting fetal tendon matrix and differentiation factors.. Stem Cells 2009 Jun;27(6):1276-87.
    pubmed: 19489094doi: 10.1002/stem.61google scholar: lookup
  53. Dale TP, Mazher S, Webb WR, Zhou J, Maffulli N, Chen GQ, El Haj AJ, Forsyth NR. Tenogenic Differentiation of Human Embryonic Stem Cells.. Tissue Eng Part A 2018 Mar;24(5-6):361-368.
    pubmed: 28548630doi: 10.1089/ten.tea.2017.0017google scholar: lookup
  54. McClellan A, Evans R, Sze C, Kan S, Paterson Y, Guest D. A novel mechanism for the protection of embryonic stem cell derived tenocytes from inflammatory cytokine interleukin 1 beta.. Sci Rep 2019 Feb 26;9(1):2755.
    pmc: PMC6391488pubmed: 30808942doi: 10.1038/s41598-019-39370-4google scholar: lookup
  55. Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression.. Nat Methods 2017 Apr;14(4):417-419.
    pmc: PMC5600148pubmed: 28263959doi: 10.1038/nmeth.4197google scholar: lookup
  56. Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences.. F1000Res 2015;4:1521.
  57. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.. Genome Biol 2014;15(12):550.
    pmc: PMC4302049pubmed: 25516281doi: 10.1186/s13059-014-0550-8google scholar: lookup
  58. Bavin EP, Atkinson F, Barsby T, Guest DJ. Scleraxis Is Essential for Tendon Differentiation by Equine Embryonic Stem Cells and in Equine Fetal Tenocytes.. Stem Cells Dev 2017 Mar 15;26(6):441-450.
    pubmed: 27899062doi: 10.1089/scd.2016.0279google scholar: lookup
  59. Xie F, Xiao P, Chen D, Xu L, Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs.. Plant Mol Biol 2012 Jan 31;.
    pubmed: 22290409doi: 10.1007/s11103-012-9885-2google scholar: lookup
  60. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.. Methods 2001 Dec;25(4):402-8.
    pubmed: 11846609doi: 10.1006/meth.2001.1262google scholar: lookup
  61. Taylor SE, Vaughan-Thomas A, Clements DN, Pinchbeck G, Macrory LC, Smith RK, Clegg PD. Gene expression markers of tendon fibroblasts in normal and diseased tissue compared to monolayer and three dimensional culture systems.. BMC Musculoskelet Disord 2009 Feb 26;10:27.
    pmc: PMC2651848pubmed: 19245707doi: 10.1186/1471-2474-10-27google scholar: lookup
  62. Kusafuka K, Hiraki Y, Shukunami C, Kayano T, Takemura T. Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage.. Acta Histochem 2002;104(2):167-75.
    pubmed: 12086337doi: 10.1078/0065-1281-00642google scholar: lookup
  63. Delany AM, Hankenson KD. Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling.. J Cell Commun Signal 2009 Dec;3(3-4):227-38.
    pmc: PMC2778593pubmed: 19862642doi: 10.1007/s12079-009-0076-0google scholar: lookup
  64. Chen J, Zhang E, Zhang W, Liu Z, Lu P, Zhu T, Yin Z, Backman LJ, Liu H, Chen X, Ouyang H. Fos Promotes Early Stage Teno-Lineage Differentiation of Tendon Stem/Progenitor Cells in Tendon.. Stem Cells Transl Med 2017 Nov;6(11):2009-2019.
    pmc: PMC6430064pubmed: 29024580doi: 10.1002/sctm.15-0146google scholar: lookup
  65. Kuemmerle JM, Theiss F, Okoniewski MJ, Weber FA, Hemmi S, Mirsaidi A, Richards PJ, Cinelli P. Identification of Novel Equine (Equus caballus) Tendon Markers Using RNA Sequencing.. Genes (Basel) 2016 Nov 10;7(11).
    pmc: PMC5126783pubmed: 27834918doi: 10.3390/genes7110097google scholar: lookup
  66. Eguizabal C, Aran B, Chuva de Sousa Lopes SM, Geens M, Heindryckx B, Panula S, Popovic M, Vassena R, Veiga A. Two decades of embryonic stem cells: a historical overview.. Hum Reprod Open 2019;2019(1):hoy024.
    pmc: PMC6396646pubmed: 30895264doi: 10.1093/hropen/hoy024google scholar: lookup
  67. Havis E, Bonnin MA, Olivera-Martinez I, Nazaret N, Ruggiu M, Weibel J, Durand C, Guerquin MJ, Bonod-Bidaud C, Ruggiero F, Schweitzer R, Duprez D. Transcriptomic analysis of mouse limb tendon cells during development.. Development 2014 Oct;141(19):3683-96.
    pubmed: 25249460doi: 10.1242/dev.108654google scholar: lookup
  68. Kapacee Z, Yeung CY, Lu Y, Crabtree D, Holmes DF, Kadler KE. Synthesis of embryonic tendon-like tissue by human marrow stromal/mesenchymal stem cells requires a three-dimensional environment and transforming growth factor β3.. Matrix Biol 2010 Oct;29(8):668-77.
  69. Maeda T, Sakabe T, Sunaga A, Sakai K, Rivera AL, Keene DR, Sasaki T, Stavnezer E, Iannotti J, Schweitzer R, Ilic D, Baskaran H, Sakai T. Conversion of mechanical force into TGF-β-mediated biochemical signals.. Curr Biol 2011 Jun 7;21(11):933-41.
    pmc: PMC3118584pubmed: 21600772doi: 10.1016/j.cub.2011.04.007google scholar: lookup
  70. Sharma RI, Snedeker JG. Biochemical and biomechanical gradients for directed bone marrow stromal cell differentiation toward tendon and bone.. Biomaterials 2010 Oct;31(30):7695-704.
  71. Shin S, Sun Y, Liu Y, Khaner H, Svant S, Cai J, Xu QX, Davidson BP, Stice SL, Smith AK, Goldman SA, Reubinoff BE, Zhan M, Rao MS, Chesnut JD. Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue.. Stem Cells 2007 May;25(5):1298-306.
    pubmed: 17272497doi: 10.1634/stemcells.2006-0660google scholar: lookup
  72. Zhang YJ, Chen X, Li G, Chan KM, Heng BC, Yin Z, Ouyang HW. Concise Review: Stem Cell Fate Guided By Bioactive Molecules for Tendon Regeneration.. Stem Cells Transl Med 2018 May;7(5):404-414.
    pmc: PMC5905226pubmed: 29573225doi: 10.1002/sctm.17-0206google scholar: lookup
  73. Liu H, Xu J, Liu CF, Lan Y, Wylie C, Jiang R. Whole transcriptome expression profiling of mouse limb tendon development by using RNA-seq.. J Orthop Res 2015 Jun;33(6):840-8.
    pmc: PMC4616261pubmed: 25729011doi: 10.1002/jor.22886google scholar: lookup
  74. Jelinsky SA, Archambault J, Li L, Seeherman H. Tendon-selective genes identified from rat and human musculoskeletal tissues.. J Orthop Res 2010 Mar;28(3):289-97.
    pubmed: 19780194doi: 10.1002/jor.20999google scholar: lookup
  75. Ito Y, Toriuchi N, Yoshitaka T, Ueno-Kudoh H, Sato T, Yokoyama S, Nishida K, Akimoto T, Takahashi M, Miyaki S, Asahara H. The Mohawk homeobox gene is a critical regulator of tendon differentiation.. Proc Natl Acad Sci U S A 2010 Jun 8;107(23):10538-42.
    pmc: PMC2890854pubmed: 20498044doi: 10.1073/pnas.1000525107google scholar: lookup
  76. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts.. Nat Genet 2009 Dec;41(12):1350-3.
    pmc: PMC2958040pubmed: 19881528doi: 10.1038/ng.471google scholar: lookup
  77. Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.. Proc Natl Acad Sci U S A 2010 Mar 2;107(9):4335-40.
    pmc: PMC2840097pubmed: 20160098doi: 10.1073/pnas.0910012107google scholar: lookup
  78. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, Chien KR, Melton DA. Marked differences in differentiation propensity among human embryonic stem cell lines.. Nat Biotechnol 2008 Mar;26(3):313-5.
    pubmed: 18278034doi: 10.1038/nbt1383google scholar: lookup
  79. Hrvatin S, O'Donnell CW, Deng F, Millman JR, Pagliuca FW, DiIorio P, Rezania A, Gifford DK, Melton DA. Differentiated human stem cells resemble fetal, not adult, β cells.. Proc Natl Acad Sci U S A 2014 Feb 25;111(8):3038-43.
    pmc: PMC3939927pubmed: 24516164doi: 10.1073/pnas.1400709111google scholar: lookup
  80. Yin Z, Hu JJ, Yang L, Zheng ZF, An CR, Wu BB, Zhang C, Shen WL, Liu HH, Chen JL, Heng BC, Guo GJ, Chen X, Ouyang HW. Single-cell analysis reveals a nestin(+) tendon stem/progenitor cell population with strong tenogenic potentiality.. Sci Adv 2016 Nov;2(11):e1600874.
    pmc: PMC5262457pubmed: 28138519doi: 10.1126/sciadv.1600874google scholar: lookup
  81. Mienaltowski MJ, Adams SM, Birk DE. Tendon proper- and peritenon-derived progenitor cells have unique tenogenic properties.. Stem Cell Res Ther 2014 Jul 8;5(4):86.
    pmc: PMC4230637pubmed: 25005797doi: 10.1186/scrt475google scholar: lookup
  82. Yagi LH, Watanuki LM, Isaac C, Gemperli R, Nakamura YM, Ladeira PRS. Human fetal wound healing: a review of molecular and cellular aspects. European Journal of Plastic Surgery 2016;39(4):239–246.
  83. Larson BJ, Longaker MT, Lorenz HP. Scarless fetal wound healing: a basic science review.. Plast Reconstr Surg 2010 Oct;126(4):1172-1180.
  84. Ellis IR, Schor SL. Differential effects of TGF-beta1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing.. Exp Cell Res 1996 Nov 1;228(2):326-33.
    pubmed: 8912726doi: 10.1006/excr.1996.0332google scholar: lookup
  85. Schor SL, Ellis I, Irwin CR, Banyard J, Seneviratne K, Dolman C, Gilbert AD, Chisholm DM. Subpopulations of fetal-like gingival fibroblasts: characterisation and potential significance for wound healing and the progression of periodontal disease.. Oral Dis 1996 Jun;2(2):155-66.
  86. Busnadiego O, González-Santamaría J, Lagares D, Guinea-Viniegra J, Pichol-Thievend C, Muller L, Rodríguez-Pascual F. LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling.. Mol Cell Biol 2013 Jun;33(12):2388-401.
    pmc: PMC3700097pubmed: 23572561doi: 10.1128/mcb.00036-13google scholar: lookup
  87. Huang M, Cai G, Baugh LM, Liu Z, Smith A, Watson M, Popovich D, Zhang T, Stawski LS, Trojanowska M, Georgakoudi I, Black LD III, Pioli PA, Whitfield ML, Garlick J. Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase-like 4: New Evidence From Three-Dimensional Skin-like Tissues.. Arthritis Rheumatol 2020 May;72(5):791-801.
    pubmed: 31705627doi: 10.1002/art.41163google scholar: lookup
  88. Gourevitch D, Kossenkov AV, Zhang Y, Clark L, Chang C, Showe LC, Heber-Katz E. Inflammation and Its Correlates in Regenerative Wound Healing: An Alternate Perspective.. Adv Wound Care (New Rochelle) 2014 Sep 1;3(9):592-603.
    pmc: PMC4152783pubmed: 25207202doi: 10.1089/wound.2014.0528google scholar: lookup
  89. Song EK, Jeon J, Jang DG, Kim HE, Sim HJ, Kwon KY, Medina-Ruiz S, Jang HJ, Lee AR, Rho JG, Lee HS, Kim SJ, Park CY, Myung K, Kim W, Kwon T, Yang S, Park TJ. ITGBL1 modulates integrin activity to promote cartilage formation and protect against arthritis.. Sci Transl Med 2018 Oct 10;10(462).
    pubmed: 30305454doi: 10.1126/scitranslmed.aam7486google scholar: lookup
  90. Liedtke D, Orth M, Meissler M, Geuer S, Knaup S, Köblitz I, Klopocki E. ECM alterations in Fndc3a (Fibronectin Domain Containing Protein 3A) deficient zebrafish cause temporal fin development and regeneration defects.. Sci Rep 2019 Sep 16;9(1):13383.
    pmc: PMC6746793pubmed: 31527654doi: 10.1038/s41598-019-50055-wgoogle scholar: lookup
  91. Helmo FR, Machado JR, Guimarães CS, Teixeira Vde P, dos Reis MA, Corrêa RR. Fetal wound healing biomarkers.. Dis Markers 2013;35(6):939-44.
    pmc: PMC3886274pubmed: 24427782doi: 10.1155/2013/567353google scholar: lookup
  92. Goldberg SR, McKinstry RP, Sykes V, Lanning DA. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression.. J Pediatr Surg 2007 Jun;42(6):966-71; discussion 971-3.
  93. Soo C, Beanes SR, Hu FY, Zhang X, Dang C, Chang G, Wang Y, Nishimura I, Freymiller E, Longaker MT, Lorenz HP, Ting K. Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization.. Am J Pathol 2003 Dec;163(6):2459-76.
  94. Ellis IR, Schor SL. Differential motogenic and biosynthetic response of fetal and adult skin fibroblasts to TGF-beta isoforms.. Cytokine 1998 Apr;10(4):281-9.
    pubmed: 9617573doi: 10.1006/cyto.1997.0294google scholar: lookup
  95. Ellis I, Banyard J, Schor SL. Differential response of fetal and adult fibroblasts to cytokines: cell migration and hyaluronan synthesis.. Development 1997 Apr;124(8):1593-600.
    pubmed: 9108375doi: 10.1242/dev.124.8.1593google scholar: lookup
  96. Han A, Bandyopadhyay B, Jayaprakash P, Lua I, Sahu D, Chen M, Woodley DT, Li W. The anti-motility signaling mechanism of TGFβ3 that controls cell traffic during skin wound healing.. Biol Open 2012 Dec 15;1(12):1169-77.
    pmc: PMC3522877pubmed: 23259050doi: 10.1242/bio.20122246google scholar: lookup
  97. Ellis I, Schor SL. The interdependent modulation of hyaluronan synthesis by TGF-beta 1 and extracellular matrix: consequences for the control of cell migration.. Growth Factors 1995;12(3):211-22.
    pubmed: 8619927doi: 10.3109/08977199509036881google scholar: lookup
  98. Schor SL. Cytokine control of cell motility: modulation and mediation by the extracellular matrix.. Prog Growth Factor Res 1994;5(2):223-48.
    pubmed: 7919226doi: 10.1016/0955-2235(94)90007-8google scholar: lookup
  99. Chen H, Seaman L, Liu S, Ried T, Rajapakse I. Chromosome conformation and gene expression patterns differ profoundly in human fibroblasts grown in spheroids versus monolayers.. Nucleus 2017 Jul 4;8(4):383-391.

Citations

This article has been cited 2 times.
  1. Smith EJ, Beaumont RE, McClellan A, Sze C, Palomino Lago E, Hazelgrove L, Dudhia J, Smith RKW, Guest DJ. Tumour necrosis factor alpha, interleukin 1 beta and interferon gamma have detrimental effects on equine tenocytes that cannot be rescued by IL-1RA or mesenchymal stromal cell-derived factors.. Cell Tissue Res 2023 Mar;391(3):523-544.
    doi: 10.1007/s00441-022-03726-6pubmed: 36543895google scholar: lookup
  2. Oreff GL, Fenu M, Vogl C, Ribitsch I, Jenner F. Species variations in tenocytes' response to inflammation require careful selection of animal models for tendon research.. Sci Rep 2021 Jun 14;11(1):12451.
    doi: 10.1038/s41598-021-91914-9pubmed: 34127759google scholar: lookup